Urologix to Transfer From NASDAQ to the OTCQB Marketplace
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
MINNEAPOLIS, June 5, 2013 (GLOBE NEWSWIRE) -- Urologix®, Inc. (Nasdaq:ULGX), the leading provider of in-office BPH therapy, announced today that its Board of Directors has authorized the transfer of the Company's common stock from The NASDAQ Capital Market ("NASDAQ") to OTC Markets Group's OTCQB Marketplace ("OTCQB"). Urologix expects that its stock will begin trading on the OTCQB under the ticker symbol "ULGX" effective June 7, 2013. As of that date, investors and other interested parties will be able to view Real Time Level II stock quotes at http://www.otcmarkets.com/stock/ULGX/quote. The OTCQB marketplace includes more than 3,100 securities representing U.S. companies that are current in their reporting requirements with the Securities and Exchange Commission or U.S. banking regulators.
Help employers find you! Check out all the jobs and post your resume.
MINNEAPOLIS, June 5, 2013 (GLOBE NEWSWIRE) -- Urologix®, Inc. (Nasdaq:ULGX), the leading provider of in-office BPH therapy, announced today that its Board of Directors has authorized the transfer of the Company's common stock from The NASDAQ Capital Market ("NASDAQ") to OTC Markets Group's OTCQB Marketplace ("OTCQB"). Urologix expects that its stock will begin trading on the OTCQB under the ticker symbol "ULGX" effective June 7, 2013. As of that date, investors and other interested parties will be able to view Real Time Level II stock quotes at http://www.otcmarkets.com/stock/ULGX/quote. The OTCQB marketplace includes more than 3,100 securities representing U.S. companies that are current in their reporting requirements with the Securities and Exchange Commission or U.S. banking regulators.
Help employers find you! Check out all the jobs and post your resume.